Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone reduction in mild-to-moderate systemic lupus erythematosus with Jieduquyuzishen recipe
ChiCTR-TRC-12001935Phase 3Completed
- Sponsor
- Zhejiang Chinese Medical University
- Start
- Jan 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of prednisone and Jiedu Quyu Zishen Fang in systemic lupus erythematosus (SLE) (2 arms), sponsored by Zhejiang Chinese Medical University. Primary endpoints: Dosage of prednisone, Systemic Lupus Erythematosus Disease Activity Index and 4 more. Started Jan 2008; status: completed.
02
Drugs
prednisoneJiedu Quyu Zishen Fang
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on ChiCTR-TRC-12001935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12001935.